2025 Annual SRNT-E Conference

Dr Deborah "Debbie" Robson is a member of the Nicotine Research Group at the National Addiction Centre, King’s College London, with over 30 years of experience in clinical practice, education, and research. Her work focuses on addressing the needs of populations often excluded from mainstream tobacco control efforts while ensuring the voices of these underserved groups are central to the research process. Debbie has co-developed and evaluated tobacco dependence treatment pathways, staff training programmes, and smokefree and e-cigarette policies within mental health services and currently leads a programme of tobacco research across acute, mental health, and community settings. Her work includes exploring the effectiveness of vaping in helping people in high-prevalence smoking groups quit and understanding its potential harms compared to smoking. She is a co-author of the Public Health England/Office of Health Improvement and Disparities commissioned e-cigarette evidence reviews 2018-2022. She also collaborates with the National Centre for Smoking Cessation and Training (UK) to develop training resources and is a Trustee for Action on Smoking and Health (England).

Dr. Maciej L. Goniewicz is a Professor of Oncology at the Department of Health Behavior, Roswell Park Comprehensive Cancer Center in Buffalo, USA. His primary research area is in nicotine pharmacology and toxicity of alternative tobacco products, with a focus on nicotine dependence and respiratory health risks. Dr. Goniewicz’s current research is focused on the safety of nicotine vaping products, heated tobacco products, and nicotine pouches. These studies include the laboratory evaluation of the products, pharmacological and toxicological assessment, user surveys, and their potential application in harm reduction and smoking cessation.

Prof. Mihălțan is a Senior Pneumologist, MD, PhD, FCCP at the Institute of Pneumophtisiology “Marius Nasta” and Professor & Head of the Pneumology Department (II) at the University of Medicine and Pharmacy “Carol Davila” in Bucharest. As a leading figure in respiratory medicine and tobacco control, his contributions have shaped national and international policies in smoking prevention, respiratory health, and sleep medicine.

Professor Dorota Kaleta has been employed at the Medical University of Łódź, Poland, since the beginning of her professional career.

In 2011, she joined the Public Health Department of the Polish Ministry of Health as an expert, where her responsibilities included reviewing documents, preparing instructions for working group meetings and committees of the European Commission, the Council of the European Union, COREPER, and the European Parliament. She also contributed to international public health cooperation efforts.

From 2008 to 2010, she served as a National Professional Officer at the World Health Organization (WHO) Country Office in Poland. In this role, she coordinated the Global Adult Tobacco Survey, tobacco control programs, and initiatives addressing chronic non-communicable diseases and environmental health. Her work included projects such as the Children's Environment and Health Action Plan for Europe (CEHAPE) and the Environment and Health Information System (ENHIS).

With extensive experience in public health, particularly in tobacco control, Professor Kaleta has played a key role in designing and implementing public health projects. She also contributed as an expert to WHO reports on tobacco use (GATS) and health inequalities in Poland.